NIKKEI 225
26,107.65 -315.82 (-1.20%) HANG SENG
21,586.66 -266.41 (-1.22%) CRUDE OIL
98.13 -1.37 (-1.38%) GOLD FUTURES
1,736.80 -27.10 (-1.54%) DOW
30,899.37 -68.45 (-0.22%) BTC-GBP
16,979.66 +390.40 (+2.35%)
Rite Aid Corporation (RAD)
| Previous close | 6.76 |
| Open | 6.73 |
| Bid | 6.86 x 1400 |
| Ask | 6.87 x 1800 |
| Day's range | 6.57 - 6.91 |
| 52-week range | 4.68 - 19.22 |
| Volume | |
| Avg. volume | 4,652,728 |
| Market cap | 382.312M |
| Beta (5Y monthly) | 1.00 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.12 |
| Earnings date | 13 Apr 2022 - 18 Apr 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 14 Oct 1999 |
| 1y target est | 3.00 |
- Motley Fool
Zoom Video Communications: Bull vs. Bear
Why Rite Aid's (NYSE: RAD) stock pop and raised guidance still aren't enough to get him interested in buying shares. Additionally, with shares down nearly 70% over the past year, is Zoom Video Communications (NASDAQ: ZM) a screaming buy or past its prime? To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.
- Yahoo Finance Video
Walgreens earnings top estimates, sales drop 4.2%
Yahoo Finance Live anchors discuss third-quarter earnings for Walgreens.
- Business Wire
Elixir Launches Specialty Generic Enhancement that Leads to Thousands in Annual Savings for Plan Sponsors and Members
PHILADELPHIA, June 30, 2022--Elixir, a wholly owned subsidiary of Rite Aid (NYSE: RAD), announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022. The enhancement allows members to receive generic versions of certain specialty medications at a $0 copay and has the potential to provide an average savings of up to $40,000 annually.
